15-year liver outcomes after metabolic surgery in patients with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH)

被引：0
|
作者：
Aminian, Ali [1 ]
ALJabri, Abdullah [1 ]
Wang, Sarah [1 ]
Bena, James [1 ]
Allende, Daniela [1 ]
Rosen, Hana [1 ]
Wilson, Rickesha [1 ]
Milinovich, Alex [1 ]
Loomba, Rohit [2 ]
Sanyal, Arun J. [3 ]
Alkhouri, Naim [4 ]
Wakim-Fleming, Jamile [1 ]
Dasarathy, Srinivasan [1 ]
McCullough, Arthur [1 ]
Nissen, Steven [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH USA
[2] Univ Calif San Diego, La Jolla, CA USA
[3] Virginia Commonwealth Univ, Richmond, VA USA
[4] Arizona Liver Hlth, Phoenix, AZ USA
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OS-125
引用
收藏
页码：S76 / S77
页数：2
相关论文
共 50 条
  • [41] Thyroid hormone receptor-b analogues for the treatment of metabolic dysfunction-associated steatohepatitis (MASH)
    Ratziu, Vlad
    Scanlan, Thomas S.
    Bruinstroop, Eveline
    JOURNAL OF HEPATOLOGY, 2025, 82 (02) : 375 - 387
  • [42] UNVEILING THE HIDDEN CONNECTION: EXPLORING THE INTERPLAY BETWEEN PERICARDITIS AND METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH)
    Ramirez, Lisnaldy
    Garzon-Siatoya, Wendy
    Aloum, Khalid
    Forlemu, Arnold Nongmoh
    Bandaru, Praneeth
    Ciobanu, Camelia
    Wakil, Ali
    Forlemu, Raissa Nana Sede Mbakop
    Krishna, Vura Naga Venkata Rama
    Sharma, Neha
    HEPATOLOGY, 2024, 80 : S472 - S472
  • [43] ECONOMIC COST OF INACTION FOR METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) IN GERMANY, JAPAN, AND THE UNITED STATES
    Younossi, Zobair
    Tacke, Frank
    Schattenberg, Joern
    Roden, Michael
    Lazarus, Jeffrey
    Allen, Alina
    Cusi, Kenneth
    Eguchi, Yuichiro
    Takahashi, Hirokazu
    Kawaguchi, Takumi
    Wong, Vincent
    Mark, Henry
    Brachowicz, Nicolai
    Henry, Linda
    Nader, Fatema
    Paik, James
    HEPATOLOGY, 2024, 80 : S816 - S817
  • [44] EXTRACELLULAR VESICLES AS A THERAPY FOR THE TREATMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) AND HEPATOCELLULAR CARCINOMA (HCC)
    Goonetilleke, M.
    Correia, J.
    Chen, Y.
    McDonald, H.
    Chan, S. T.
    Simpson, I.
    Inocencio, I. M.
    Sievert, W.
    Lim, R.
    CYTOTHERAPY, 2024, 26 (06) : S75 - S76
  • [45] Cost of inaction for metabolic dysfunction-associated steatohepatitis (MASH): the projected economic burden in the United States
    Younossi, Zobair
    Lazarus, Jeffrey V.
    Allen, Alina M.
    Cusi, Kenneth
    Tacke, Frank
    Roden, Michael
    Schattenberg, Jorn M.
    Mark, Henry E.
    Henry, Linda
    Nader, Fatema
    Paik, James M.
    JOURNAL OF HEPATOLOGY, 2024, 80 : S470 - S471
  • [46] Prediction and characterization of post-liver transplant metabolic dysfunction-associated steatohepatitis (MASH) using deep machine learning
    Ghosh, S.
    Naimimohasses, S.
    Prayitno, K.
    Azhie, A.
    Hodar, L. Gonzalez
    Pasini, E.
    Satapathy, S.
    Rotman, Y.
    Bhat, M.
    LIVER TRANSPLANTATION, 2024, 30 : 252 - 252
  • [47] Metabolic profiling of adipose tissues in metabolic dysfunction-associated steatohepatitis (MASH): insights from lipidomic, proteomic, and epigenetic analyses in morbidly obese patients undergoing bariatric surgery
    Placed-Gallego, Cristina
    Manuel Jimenez-Aguilar, Juan
    Onoiu, Alina-Iuliana
    Cambra-Cortes, Vicente
    Jimenez-Franco, Andrea
    Martinez-Navidad, Cristian
    Castane, Helena
    Camps, Jordi
    Joven, Jorge
    JOURNAL OF HEPATOLOGY, 2024, 80 : S583 - S584
  • [48] The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients
    Paklar, Natasa
    Mijic, Maja
    Filipec-Kanizaj, Tajana
    BIOMEDICINES, 2023, 11 (11)
  • [49] IMPROVED DIAGNOSTIC ACCURACY OF VIBRATION-CONTROLLED TRANSIENT ELASTOGRAPHY BASED TESTS IN IDENTIFYING METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) AND AT-RISK MASH IN OBESE AND LEAN INDIVIDUALS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Quek, Joo Wei Ethan
    Tan, En Ying
    Lee, Shi Yan
    Huang, Daniel
    Lee, Jonathan
    Teng, Margaret
    Ng, Cheng Han
    Syn, Nicholas
    Wee, Aileen
    Soon, Shook Ting Gwyneth
    Jumat, Nur Halisah
    Dan, Yock Young
    Muthiah, Mark
    HEPATOLOGY, 2024, 80 : S620 - S621
  • [50] Metabolic dysfunction-associated fatty liver disease: a year in review
    Alharthi, Jawaher
    Gastaldelli, Amalia
    Cua, Ian Homer
    Ghazinian, Hasmik
    Eslam, Mohammed
    CURRENT OPINION IN GASTROENTEROLOGY, 2022, 38 (03) : 251 - 260
12345